|
|
|
201-500 employees
View all
|
|
biotechnology
|
|
111 W Lemon Ave floor 2,Monrovia,CA,US
|
|
Antibodies by Design Antibody and protein biotherapeutics are changing the way physicians treat autoimmune diseases, asthma, and cancer. At Xencor, we apply proprietary protein engineering technologies to develop better biotherapeutics – antibodies that target new biological mechanisms and are more potent, safer and longer lasting – to improve patient outcomes and quality of life. Our XmAb antibody engineering technology dramatically augments natural antibody immune functions while maintaining over 99.5% identity to natural antibodies. This combination of new, highly potent activities while maintaining the beneficial drug features and simplicity of natural antibodies allows us to create differentiated drug candidates with potential for breakthrough performance. The XmAb® platform has resulted in a robust pipeline of antibody product candidates, including eight in human clinical trials being developed by Xencor and by pharmaceutical partners. Xencor is also discovering biologics products that improve the performance of old antibody drugs, known as biosuperiors, to benefit patients, ease compliance and help reduce costs.
|
Xencor Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
41.67%
|
The widely used Xencor email format is {f}{last} (e.g. [email protected]) with 41.67% adoption across the company.
To contact Xencor customer service number in your country click here to find.
Bassil Dahiyat is the CEO of Xencor. To contact Bassil Dahiyat email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.